These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18023106)

  • 1. Sirolimus-induced drug fever and ciclosporin-induced leukencephalopathia with seizures in one liver transplant recipient.
    Schacherer D; Zeitoun M; Buttner R; Gelbmann C; Obed A; Schlitt HJ; Scholmerich J; Kirchner GI
    World J Gastroenterol; 2007 Dec; 13(45):6090-3. PubMed ID: 18023106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus and mycophenolate mofetil after liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
    Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
    Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
    Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
    DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
    Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus-induced drug fever in a renal transplant patient: a case report.
    Aires I; Carvalho D; Remédio F; Possante M; Ferreira A; Pinto JR; Nolasco F; Santos JR
    Transplant Proc; 2009 Apr; 41(3):957-8. PubMed ID: 19376397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
    Watson CJ; Gimson AE; Alexander GJ; Allison ME; Gibbs P; Smith JC; Palmer CR; Bradley JA
    Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demyelinating sensorimotor polyneuropathy associated with the use of sirolimus: a case report.
    Bilodeau M; Hassoun Z; Brunet D
    Transplant Proc; 2008 Jun; 40(5):1545-7. PubMed ID: 18589148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus.
    Casas-Melley AT; Falkenstein KP; Flynn LM; Ziegler VL; Dunn SP
    Pediatr Transplant; 2004 Aug; 8(4):362-6. PubMed ID: 15265163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus conversion for renal preservation in liver transplantation: not so fast.
    Jensen GS; Wiseman A; Trotter JF
    Liver Transpl; 2008 May; 14(5):601-3. PubMed ID: 18433068
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation.
    Paramesh AS; Grosskreutz C; Florman SS; Gondolesi GE; Sharma S; Kaufman SS; Fishbein TM
    Transplantation; 2004 Jan; 77(1):129-31. PubMed ID: 14724447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors.
    Di Benedetto F; Di Sandro S; De Ruvo N; Spaggiari M; Montalti R; Ballarin R; Cappelli G; Gerunda GE
    J Clin Gastroenterol; 2009 Mar; 43(3):280-6. PubMed ID: 19057397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus-induced thrombotic microangiopathy in a renal transplant recipient.
    Barone GW; Gurley BJ; Abul-Ezz SR; Gökden N
    Am J Kidney Dis; 2003 Jul; 42(1):202-6. PubMed ID: 12830473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
    Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus-associated hepatotoxicity in liver transplantation.
    Neff GW; Ruiz P; Madariaga JR; Nishida S; Montalbano M; Meyer D; Levi DM; Tzakis AG; O'Brien CB
    Ann Pharmacother; 2004 Oct; 38(10):1593-6. PubMed ID: 15328399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution.
    Toth CC; Burak K; Becker W
    Headache; 2005 Mar; 45(3):245-6. PubMed ID: 15836601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment: delayed wound healing with sirolimus after liver transplant.
    Mathis AS
    Ann Pharmacother; 2003 Mar; 37(3):453. PubMed ID: 12639183
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdomyolysis as a clinical manifestation of association with ciprofibrate, sirolimus, cyclosporine, and pegylated interferon-α in liver-transplanted patients: a case report and literature review.
    dos Santos AG; Guardia AC; Pereira TS; Ataíde EC; Mei Md; Udo ME; Boin IF; Stucchi RS
    Transplant Proc; 2014; 46(6):1887-8. PubMed ID: 25131061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit-risk assessment of sirolimus in renal transplantation.
    Kuypers DR
    Drug Saf; 2005; 28(2):153-81. PubMed ID: 15691225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.